Circumventing human limits in precision oncology: AI-enhanced tailoring of post-operative treatment for pancreatic ductal adenocarcinoma

Ann Oncol. 2024 Sep;35(9):760-761. doi: 10.1016/j.annonc.2024.05.547.

Authors

S Casalino¹, C Zecchetto¹, V Merz¹, A Quinzii¹, S Pietrobono¹, D Melisi²

Affiliations

¹ Digestive Molecular Clinical Oncology Research Unit, University of Verona, Verona, Italy.
² Digestive Molecular Clinical Oncology Research Unit, University of Verona, Verona, Italy; Investigational Cancer Therapeutics Clinical Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy. Electronic address: [email protected].

PMID: 39214630
DOI: 10.1016/j.annonc.2024.05.547

No abstract available

Publication types

Letter
Editorial

MeSH terms

Artificial Intelligence
Carcinoma, Pancreatic Ductal* / drug therapy
Carcinoma, Pancreatic Ductal* / pathology
Carcinoma, Pancreatic Ductal* / surgery
Carcinoma, Pancreatic Ductal* / therapy
Humans
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / pathology
Pancreatic Neoplasms* / surgery
Precision Medicine* / methods